Small Molecule vs. Biologic: Tailoring Your Drug Patent LOE Strategy for Generics vs. Biosimilars
Small Molecules vs. Biologics: The “Same” Patent Fight—But a Completely Different Playbook for Generics vs. Biosimilars
Most people treat drug patent strategy like a single sport: find the weak link, challenge the claims, and win the market. But when y…
